News
RDD® Europe 2011 in Berlin brought together pulmonary and nasal drug delivery experts from more than 30 countries for a unique exchange of knowledge, expertise, science and business networking. 465 delegates involved in pulmonary and nasal drug delivery attended the fourth RDD (Respiratory Drug Delivery) Europe conference in Germany last week. The largest RDD Europe meeting to date RDD Europe 2011 (May 3-6) attracted a record attendance from across Europe (70%), the United States (22%) and the rest of the world (8%). The joint organizers of this increasingly prestigious meeting, RDD Online® and Aptar Pharma, were delighted that this scientific conference was such a success, which they largely attribute to the hard work of 24 speakers, 65 scientific poster presenters, 56 company exhibitors, and 12 technical workshop facilitators; and to the participation of a large and lively audience. A unique scientific event bringing the Respiratory World together Feedback from meeting participants shows that RDD Europe has a large following and is considered to be one of the leading international scientific conferences in this niche pharmaceutical sector. This is due to the active engagement of academic, industrial and regulatory scientists involved in research, development, clinical evaluation and marketing of existing and new medicines delivered through the lungs or nose. At RDD Europe 2011 the program and debates focused on ‘Drug Development Challenges – New Drugs, Formulations and Devices,’ ‘Science in Product Development : Advances in Processing, Formulation and Characterization’ ,’LABA and LABA-ICS Post-Market Trial Design’, ‘Comprehending Drug Delivery through Advanced Imaging’ and ‘Debating Efficient Data Analysis Methods for Abbreviated Impactor Measurements’. Following a model established at RDD 2010 in the United States with the Product Quality Research Institute (PQRI), RDD Europe 2011 was coordinated with a satellite meeting hosted by the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). This coordinated meeting delved into ‘Perspectives on Effi cient Data Analysis Methods and Abbreviated Impactor Measurements as Quality Assessment Tools.’ “When facilitating coordinated meetings, we try hard to program topics of value to the widest possible audience and attempt to save delegates from wasted travel time and unnecessary expense”, noted Dr. Richard Dalby, one of the organizers from the University of Maryland. “With Aptar Pharma and RDD Online expertise driving it, RDD Europe has become the reference in terms of scientifi c conferences”, said Pierre Carlotti, Vice President Marketing and Communication, Aptar Pharma, Prescription division. Next Meetings: RDD 2012 in Phoenix, Arizona, USA and RDD Europe 2013 in Athens, Greece RDD Online and Virginia Commonwealth University are planning RDD 2012. If the 20+ year history of these meetings is a guide to future attendance, over 700 participants, 120 poster presenters and 75 exhibitors will converge on Phoenix, Arizona, from May 13-17, 2012, for the next Respiratory Drug Delivery conference. Building on the success of the latest meeting in Europe, Aptar Pharma and RDD Online are working hard to develop an exciting program for RDD Europe 2013 in Athens, Greece, from May 21-24, 2013.
Aptar Pharma is part of the Aptargroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. We create innovative drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world. We provide our customers with a wide range of delivery technologies and analytical services backed by years of proven expertise. Aptargroup (NYSE: ATR) is headquartered in the US and has manufacturing sites in North America, Europe, Asia and South America. For more information, visit www.aptar.com.
RDD Online manages the organization of Respiratory Drug Delivery meetings in the US, and partners with Aptar Pharma to run RDD meetings in Europe. Other RDD Online services available at www.rddonline.com include providing scientifi c and technical publications, web-based training, textbook publishing, service directories and recruiting services of interest to companies active in pulmonary and nasal drug delivery. For more information, please visit www.rddonline.com.
Elisa Eschylle, Events and Press relations manager Tel.: + 33 (0)1 39 17 20 41 Email : elisa.eschylle@aptar.com Marion Baschet Vernet Tel.: +44 (0)797 609 4100 Email : mbvernet@gmail.com
Download the press release in PDF format < Back